ARAP3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-1315
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Bovine (100%), Canine (100%), Mouse (100%), Porcine (100%). Backed by our 100% Guarantee.
Applications
Immunoprecipitation, Peptide ELISA
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence CTSSPPSSQPLT corresponding to C-Terminus according to NP_071926.4.
Localization
Nuclear
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for ARAP3 Antibody
Application
Recommended Usage
Immunoprecipitation
1:50
Peptide ELISA
Detection limit 1:4000
Application Notes
IP successful usage on scirrhous human gastric cancer cell lines. WB successful usage on scirrhous human gastric cancer cell lines is reported in scientific literature (PMID: 210764690).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: ARAP3
Alternate Names
Arf and Rho GAP adapter protein 3, arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3, ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, ARF-GAP, RHO-GAP, ankyrin repeat and plekstrin homology domains-containingprotein 3, centaurin, delta 3, centaurin-delta-3, CENTD3, cnt-d3, DRAG1, FLJ21065, phosphoinositide binding protein, PtdIns(34,5)P3-binding protein
Entrez Gene IDs
64411 (Human)
Gene Symbol
ARAP3
UniProt
Additional ARAP3 Products
Product Documents for ARAP3 Antibody
Product Specific Notices for ARAP3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...